STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
23 hedge funds and large institutions have $2.81M invested in Statera Biopharma, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
35% less capital invested
Capital invested by funds: $4.31M → $2.81M (-$1.49M)
Holders
23
Holding in Top 10
–
Calls
$40K
Puts
$24K
Top Buyers
| 1 | +$759K | |
| 2 | +$53.7K | |
| 3 | +$45K | |
| 4 |
Renaissance Technologies
New York
|
+$37.3K |
| 5 |
DY
Dowling & Yahnke
San Diego,
California
|
+$34K |
Top Sellers
| 1 | -$77.7K | |
| 2 | -$69K | |
| 3 | -$26.1K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$20K |
| 5 |
US Bancorp
Minneapolis,
Minnesota
|
-$5K |